Anticancer Research: 34 (4)

April 2014; Volume 34,Issue 4

Special Issue on New Anticancer Agents

Reviews

You have access
Family of Peptides Synthesized in the Human Body Have Anticancer Effects
DAVID L. VESELY

Anticancer Research April 2014, 34 (4) 1459-1466;
You have access
Targeting Extracellular ROS Signaling of Tumor Cells
GEORG BAUER

Anticancer Research April 2014, 34 (4) 1467-1482;
You have access
Pertuzumab: Development Beyond Breast Cancer
PHILIPPE BARTHÉLÉMY, JULIE LEBLANC, VERONICA GOLDBARG, FRÉDÉRIQUE WENDLING and JEAN-EMMANUEL KURTZ

Anticancer Research April 2014, 34 (4) 1483-1491;
You have access
New Developments in the Treatment of Metastatic Melanoma: Immune Checkpoint Inhibitors and Targeted Therapies
KAAMAR AZIJLI, ELLEN STELLOO, GODEFRIDUS J. PETERS and ALFONS J.M. VAN DEN EERTWEGH

Anticancer Research April 2014, 34 (4) 1493-1505;
You have access
Treatment of Acute Promyelocytic Leukemia
EHAB ELBAHESH, NIHAR PATEL and IMAD A. TABBARA

Anticancer Research April 2014, 34 (4) 1507-1517;
You have access
Targeted Treatment of Ovarian Cancer - The Multiple - Kinase - Inhibitor Sorafenib as a Potential Option
ELISABETH SMOLLE, VALENTIN TAUCHER, EDGAR PETRU and JOHANNES HAYBAECK

Anticancer Research April 2014, 34 (4) 1519-1530;
You have access
Molecular Basis of 5-Fluorouracil-related Toxicity: Lessons from Clinical Practice
PANAGIOTIS PAPANASTASOPOULOS and JUSTIN STEBBING

Anticancer Research April 2014, 34 (4) 1531-1535;
You have access
The Use of Bevacizumab in Non-Small Cell Lung Cancer: An Update
SALVATORE LAURO, CONCETTA ELISA ONESTI, RICCARDO RIGHINI and PAOLO MARCHETTI

Anticancer Research April 2014, 34 (4) 1537-1545;
You have access
Effective Targeting of the Epidermal Growth Factor Receptor (EGFR) for Treating Oral Cancer: A Promising Approach
FLÁVIA ANDRESSA PIDONE RIBEIRO, JULIANA NOGUTI, CELINA TIZUKO FUJIYAMA OSHIMA and DANIEL ARAKI RIBEIRO

Anticancer Research April 2014, 34 (4) 1547-1552;
You have access
Malignant Ascites in Ovarian Cancer and the Role of Targeted Therapeutics
ELISABETH SMOLLE, VALENTIN TAUCHER and JOHANNES HAYBAECK

Anticancer Research April 2014, 34 (4) 1553-1561;
You have access
New Possibilities in Hepatocellular Carcinoma Treatment
MAHMOOD RASOOL, SANA RASHID, MAHWISH AROOJ, SHAKEEL AHMED ANSARI, KHALID MAHMUD KHAN, ARIF MALIK, MUHAMMAD IMRAN NASEER, SARA ZAHID, ABDUL MANAN, MUHAMMAD ASIF, ZARISH RAZZAQ, SADIA ASHRAF, MAHMOOD HUSAIN QAZI, ZAFAR IQBAL, SIEW HUA GAN, MOHAMMAD AMJAD KAMAL and ISHFAQ AHMED SHEIKH

Anticancer Research April 2014, 34 (4) 1563-1571;
You have access
New Anticancer Agents: Role of Clinical Pharmacy Services
DOMINIQUE LEVEQUE, AMINA DELPEUCH and BENEDICTE GOURIEUX

Anticancer Research April 2014, 34 (4) 1573-1578;
You have access
Subcutaneous Administration of Anticancer Agents
DOMINIQUE LEVEQUE

Anticancer Research April 2014, 34 (4) 1579-1586;
You have access
New Treatment Paradigm for Patients with Anaplastic Oligodendroglial Tumors
JIRI POLIVKA, JIRI POLIVKA, VLADIMIR ROHAN and ONDREJ TOPOLCAN

Anticancer Research April 2014, 34 (4) 1587-1594;
You have access
Targeting Tropomyosin-receptor Kinase Fused Gene in Cancer
YUN CHEN and SHENG-HONG TSENG

Anticancer Research April 2014, 34 (4) 1595-1600;

Experimental Studies

You have access
Cytotoxic Activity of N, N’-Bis (2-hydroxybenzyl) ethylenediamine Derivatives in Human Cancer Cell Lines
MUSILIYU A. MUSA, VEERA L. D. BADISA and LEKAN M. LATINWO

Anticancer Research April 2014, 34 (4) 1601-1607;
You have access
The Addition of a Pregnenolone Pendant Group Enhances the Anticancer Properties of Titanocene Dichloride in a MCF-7 Xenograft Model
GLADIANY RAMOS, YALIZ LOPERENA, GIOVANNI ORTIZ, FIORELLA REYES, ADA SZETO, JOSE VERA, JAVIER VELEZ, JESSICA MORALES, DEBORAH MORRERO, LINNETTE CASTILLO, SURANGANI DHARMAWARDHANE, ENRIQUE MELENDEZ and A. VALANCE WASHINGTON

Anticancer Research April 2014, 34 (4) 1609-1615;
You have access
Ascorbic Acid Induces either Differentiation or Apoptosis in MG-63 Osteosarcoma Lineage
MARIA TERESA VALENTI, MIRKO ZANATTA, LUCA DONATELLI, GIANMARIA VIVIANO, CHIARA CAVALLINI, MARIA TERESA SCUPOLI and LUCA DALLE CARBONARE

Anticancer Research April 2014, 34 (4) 1617-1627;
You have access
Bosutinib Reduces the Efficacy of Dasatinib in Triple-negative Breast Cancer Cell Lines
MIKE TARPLEY, TEMESGEN T. ABDISSA, GARY L. JOHNSON and JOHN E. SCOTT

Anticancer Research April 2014, 34 (4) 1629-1635;
You have access
Specific RSK Kinase Inhibition by Dibenzyl Trisulfide and Implication for Therapeutic Treatment of Cancer
HENRY I.C. LOWE, CAROLINE O.B. FACEY, NGEH J. TOYANG and JOSEPH L. BRYANT

Anticancer Research April 2014, 34 (4) 1637-1641;
You have access
Mechanisms by which Synthetic 6,7-Annulated-4-substituted Indole Compounds with Anti-proliferative Activity Disrupt Mitosis and Block Cytokinesis in Human HL-60 Tumor Cells In Vitro
JEAN-PIERRE H. PERCHELLET, ELISABETH M. PERCHELLET, CHINGAKHAM RANJIT SINGH, MEGHAN T. MONNETT, ELIZABETH R. STUDER, PAUL D. THORNTON, NEIL BROWN, DAVID HILL, BEN NEUENSWANDER, GERALD H. LUSHINGTON, CONRAD SANTINI and KEITH R. BUSZEK

Anticancer Research April 2014, 34 (4) 1643-1655;
You have access
Cytarabine-resistant Leukemia Cells Are Moderately Sensitive to Clofarabine In Vitro
TAKAHIRO YAMAUCHI, KANAKO UZUI, RIE NISHI, HIROKO SHIGEMI and TAKANORI UEDA

Anticancer Research April 2014, 34 (4) 1657-1662;
You have access
Inhibitory Effect of Orally-administered Sulfated Polysaccharide Ascophyllan Isolated from Ascophyllum nodosum on the Growth of Sarcoma-180 Solid Tumor in Mice
ZEDONG JIANG, RYOGO ABU, SHOGO ISAKA, SATORU NAKAZONO, MIKINORI UENO, TAKASI OKIMURA, KENICHI YAMAGUCHI and TATSUYA ODA

Anticancer Research April 2014, 34 (4) 1663-1671;
You have access
Anticancer Activity of Novel pyrido[2,3-b]indolizine Derivatives: The Relevance of Phenolic Substituents
ARNOUD BOOT, ALEXANDRA BRITO, TOM VAN WEZEL, HANS MORREAU, MARTA COSTA and FERNANDA PROENÇA

Anticancer Research April 2014, 34 (4) 1673-1677;
You have access
Uptake and Efflux of Rhenium in Cells Exposed to Rhenium Diseleno-Ether and Tissue Distribution of Rhenium and Selenium After Rhenium Diseleno-Ether Treatment in Mice
PHILIPPE COLLERY, GÉRARD BASTIAN, FRANÇOIS SANTONI, AHMED MOHSEN, MING WEI, THOMAS COLLERY, ALAIN TOMAS, DIDIER DESMAELE and JEAN D'ANGELO

Anticancer Research April 2014, 34 (4) 1679-1689;
You have access
Quercetin-3-O-glucoside Induces Human DNA Topoisomerase II Inhibition, Cell Cycle Arrest and Apoptosis in Hepatocellular Carcinoma Cells
SUDHANSHU SUDAN and H.P. VASANTHA RUPASINGHE

Anticancer Research April 2014, 34 (4) 1691-1699;
You have access
Sodium Butyrate, a Histone Deacetylase Inhibitor, Regulates Lymphangiogenic Factors in Oral Cancer Cell Line HSC-3
TAKASHI YAMAMURA, NAOYUKI MATSUMOTO, YASUYOSHI MATSUE, MICHISATO OKUDERA, YOUICHI NISHIKAWA, YOSHIMITSU ABIKO and KAZUO KOMIYAMA

Anticancer Research April 2014, 34 (4) 1701-1708;
You have access
Synergistic Inhibition of HCC and Liver Cancer Stem Cell Proliferation by Targeting RAS/RAF/MAPK and WNT/β-Catenin Pathways
ROBERTO GALUPPO, ERIN MAYNARD, MALAY SHAH, MICHAEL F. DAILY, CHANGGUO CHEN, BRETT T. SPEAR and ROBERTO GEDALY

Anticancer Research April 2014, 34 (4) 1709-1713;
You have access
Enhanced Efficacy of CKD-516 in Combination with Doxorubicin: Pre-clinical Evaluation Using a Hepatocellular Carcinoma Xenograft Model
YOUNG IL KIM, KYUNG WON KIM, HAN KYU LEE, JISUK PARK, JIN WOOK CHUNG, HYEWON YOUN, SOO JIN KIM, DAL-HYUN KIM, JEN-CHIEH TSENG and JEONG MIN LEE

Anticancer Research April 2014, 34 (4) 1715-1722;
You have access
Silibinin Down-regulates Expression of Secreted Phospholipase A₂ Enzymes in Cancer Cells
ALBERT HAGELGANS, BRIT NACKE, MARIA ZAMARAEVA, GABRIELE SIEGERT and MARIO MENSCHIKOWSKI

Anticancer Research April 2014, 34 (4) 1723-1729;
You have access
Endoplasmic Reticulum Stress Response as a Possible Mechanism of Cyclooxygenase-2-independent Anticancer Effect of Celecoxib
WONJAE CHA, SEOK-WOO PARK, TACK-KYUN KWON, J. HUN HAH and MYUNG-WHUN SUNG

Anticancer Research April 2014, 34 (4) 1731-1735;
You have access
Multidrug Resistance Reversing Activity of Newly Developed Phenothiazines on P-glycoprotein (ABCB1)-related Resistance of Mouse T-Lymphoma Cells
GABRIELLA SPENGLER, DANIELLA TAKÁCS, ÁDÁM HORVÁTH, ZSUZSANNA RIEDL, GYÖRGY HAJÓS, LEONARD AMARAL and JÓZSEF MOLNÁR

Anticancer Research April 2014, 34 (4) 1737-1741;
You have access
Quantitative Structure–Activity Relationship Analysis of Cytotoxicity and Anti-UV Activity of 2-Aminotropones
SHOTA SEKINE, CHISATO SHIMODAIRA, YOSHIHIRO UESAWA, HAJIME KAGAYA, YUMIKO KANDA, MARIKO ISHIHARA, OSAMU AMANO, HIROSHI SAKAGAMI and HIDETSUGU WAKABAYASHI

Anticancer Research April 2014, 34 (4) 1743-1750;
You have access
Translymphatic Chemotherapy Targeting Sentinel Lymph Nodes Using a Novel Phospholipid Polymer–Paclitaxel Conjugate
TAKASHI OYAMA, HIROYA TAKEUCHI, SACHIKO MATSUDA, SOJI OZAWA, MASAKI KITAJIMA and YUKO KITAGAWA

Anticancer Research April 2014, 34 (4) 1751-1757;
You have access
Dipalmitoleoyl-phosphatidylethanolamine Induces Apoptosis of NCI-H28 Malignant Mesothelioma Cells
YOSHIKO KAKU, AYAKO TSUCHIYA, TAKESHI KANNO, TAKASHI NAKANO and TOMOYUKI NISHIZAKI

Anticancer Research April 2014, 34 (4) 1759-1764;
You have access
Metformin Suppresses Sonic Hedgehog Expression in Pancreatic Cancer Cells
MASAFUMI NAKAMURA, AYAKO OGO, MASAHIRO YAMURA, YOSHIYUKI YAMAGUCHI and HIROSHI NAKASHIMA

Anticancer Research April 2014, 34 (4) 1765-1769;
You have access
A Novel Tetramethylnaphthalene Derivative Selectively Inhibits Adult T-Cell Leukemia (ATL) Cells In Vitro
MASAAKI TOYAMA, HIROSHI AOYAMA, RISA MUKAI, MASAHARU NAKAMURA, KOJI YOSHIMURA, MIKA OKAMOTO, TAKAYUKI OHSHIMA, YUICHI HASHIMOTO and MASANORI BABA

Anticancer Research April 2014, 34 (4) 1771-1778;
You have access
Synergistic Cytotoxic Activity of Treosulfan and Gemcitabine in Pancreatic Cancer Cell Lines
EMILIA NITSCH, SORMEH MINA, INGO BRAMMER, ANDREA PACE, GUNTER SCHUCH, CARSTEN BOKEMEYER, AXEL ZANDER, NICOLAUS KRÖGER and FRANCIS AYUK

Anticancer Research April 2014, 34 (4) 1779-1784;
You have access
Antiproliferative and Apoptosis-inducing Activity of Nobiletin Against Three Subtypes of Human Breast Cancer Cell Lines
CHEN CHEN, MISAKI ONO, MIKAKO TAKESHIMA and SHUJI NAKANO

Anticancer Research April 2014, 34 (4) 1785-1792;
You have access
COX2 Inhibitor NS398 Reduces HT-29 Cell Invasiveness by Modulating Signaling Pathways Mediated by EGFR and HIF1-α
CLAUDIA BOCCA, FRANCESCA BOZZO and ANTONELLA MIGLIETTA

Anticancer Research April 2014, 34 (4) 1793-1800;
You have access
Behavior-selective Apoptotic Capacity of 4-(3,4,5-Trimethoxyphenoxy) Benzoic Acid and its Methyl Derivatives on Two Breast Cancer Cell Lines
KUAN-HAN LEE, WEN-YUEH HO, SHU-JING WU, TSUNG-LIN CHENG, PO-JUI HUANG, CLAY C.C. WANG and JUI-HSIANG HUNG

Anticancer Research April 2014, 34 (4) 1801-1809;
You have access
3,3’,4’, 5’-Tetramethoxychalcone Inhibits Human Oral Cancer Cell Proliferation and Migration via p53-mediated Mitochondrial-dependent Apoptosis
CHENG-KUO LAI, YERRA KOTESWARA RAO, KAI-RUEI CHANG, CHENG-WEN LIN, HONG-LIN SU, CHIA-SHUO CHANG, CHIH-HO LAI and YEW-MIN TZENG

Anticancer Research April 2014, 34 (4) 1811-1819;
You have access
Activation of AXL and Antitumor Effects of a Monoclonal Antibody to AXL in Lung Adenocarcinoma
SHINYA IIDA, YASUHIRO MIKI, TAKASHI SUZUKI, KAZUSHIGE MORI, MIKIYOSHI SAITO, HIROMICHI NIIKAWA, TAKASHI KONDO, HISAFUMI YAMADA-OKABE and HIRONOBU SASANO

Anticancer Research April 2014, 34 (4) 1821-1827;
You have access
Induction of Apoptosis by Deinoxanthin in Human Cancer Cells
YONG-JI CHOI, JUNG-MU HUR, SANGYONG LIM, MINHO JO, DONG HO KIM and JONG-IL CHOI

Anticancer Research April 2014, 34 (4) 1829-1835;
You have access
A Monastrol-derived Compound, LaSOM 63, Inhibits Ecto-5’Nucleotidase/CD73 Activity and Induces Apoptotic Cell Death of Glioma Cell Lines
FABRÍCIO FIGUEIRÓ, FRANCIANE BRACKMANN MENDES, PATRICIA FRASSON CORBELINI, FERNANDA JANARELLI, ELISA HELENA FARIAS JANDREY, DENNIS RUSSOWSKY, VERA LUCIA EIFLER-LIMA and ANA MARIA OLIVEIRA BATTASTINI

Anticancer Research April 2014, 34 (4) 1837-1842;
You have access
Effects of Angiotensin, Vasopressin and Aldosterone on Proliferation of MCF-7 Cells and Their Sensitivity to Doxorubicin
JOÃO MARCOS DE AZEVEDO DELOU, ANIBAL GIL LOPES and MÁRCIA ALVES MARQUES CAPELLA

Anticancer Research April 2014, 34 (4) 1843-1848;
You have access
Combinatorial Effects of PARP Inhibitor PJ34 and Histone Deacetylase Inhibitor Vorinostat on Leukemia Cell Lines
EWA JASEK, MARIUSZ GAJDA, GRZEGORZ J. LIS, MAŁGORZATA JASIŃSKA and JAN A. LITWIN

Anticancer Research April 2014, 34 (4) 1849-1856;
You have access
Curcumin Suppresses Vasculogenic Mimicry Capacity of Hepatocellular Carcinoma Cells through STAT3 and PI3K/AKT Inhibition
KHAJEELAK CHIABLAEM, KRIENGSAK LIRDPRAPAMONGKOL, SIRIPORN KEERATICHAMROEN, RUDEE SURARIT and JISNUSON SVASTI

Anticancer Research April 2014, 34 (4) 1857-1864;
You have access
Potent Reactive Oxygen Species-JNK-p38 Activation by Sodium Salicylate Potentiates Death of Primary Effusion Lymphoma Cells
KULTHIDA VAETEEWOOTTACHARN, MANTHANA MITCHAI, PATTARAVADEE SRIKOON, SHINICHIRO HATTORI, RYUSHO KARIYA, KOUKI MATSUDA, SOPIT WONGKHAM and SEIJI OKADA

Anticancer Research April 2014, 34 (4) 1865-1871;
You have access
Impact of S100A8 Expression on Kidney Cancer Progression and Molecular Docking Studies for Kidney Cancer Therapeutics
ZEENAT MIRZA, HANS-JUERGEN SCHULTEN, HASAN MA FARSI, JAUDAH A. AL-MAGHRABI, MAMDOOH A. GARI, ADEEL GA CHAUDHARY, ADEL M. ABUZENADAH, MOHAMMED H. AL-QAHTANI and SAJJAD KARIM

Anticancer Research April 2014, 34 (4) 1873-1884;
You have access
The Influence of Retinoic Acid and Thalidomide on the Radiosensitivity of U343 Glioblastoma Cells
DUŠAN MILANOVIĆ, PATRICK MAIER, DANIEL H. SCHANNE, FREDERIK WENZ and CARSTEN HERSKIND

Anticancer Research April 2014, 34 (4) 1885-1891;
You have access
Piperine Enhances the Efficacy of TRAIL-based Therapy for Triple-negative Breast Cancer Cells
SHERIF ABDELHAMED, SATORU YOKOYAMA, ALAA REFAAT, KEISUKE OGURA, HIDEO YAGITA, SURESH AWALE and IKUO SAIKI

Anticancer Research April 2014, 34 (4) 1893-1899;
You have access
Novel Ruthenium – Gamma-linolenic Acid Complex Inhibits C6 Rat Glioma Cell Proliferation In Vitro and in the Orthotopic C6 Model In Vivo After Osmotic Pump Infusion
JULIANO ANDREOLI MIYAKE, MARCEL BENADIBA, GEISE RIBEIRO, DENISE DE OLIVEIRA SILVA and ALISON COLQUHOUN

Anticancer Research April 2014, 34 (4) 1901-1911;
You have access
Radiosensitizing Effect of Rosmarinic Acid in Metastatic Melanoma B16F10 Cells
MIGUEL ALCARAZ, MIGUEL ALCARAZ-SAURA, DANIEL GYINGIRI ACHEL, AMPARO OLIVARES, JOSÉ ANTONIO LÓPEZ-MORATA and JULIÁN CASTILLO

Anticancer Research April 2014, 34 (4) 1913-1921;
You have access
Synthesis and Antitumour Activity of a New Trinuclear Platinum Compound [{cis-PtCl(NH₃)₂μ {trans-Pt(3-hydroxypyridine)₂H₂N(CH₂)₅NH₂)₂}] Cl₄ in Human Ovarian Cancer Cells
SHAHNAZ A. HAMAD, PHILIP BEALE, JUN QING YU and FAZLUL HUQ

Anticancer Research April 2014, 34 (4) 1923-1929;
You have access
A Bibenzyl from Dendrobium ellipsophyllum Inhibits Epithelial-to-Mesenchymal Transition and Sensitizes Lung Cancer Cells to Anoikis
CHATCHAI CHAOTHAM, VARISA PONGRAKHANANON, BOONCHOO SRITULARAK and PITHI CHANVORACHOTE

Anticancer Research April 2014, 34 (4) 1931-1938;

Clinical Studies

You have access
Pediatric Patients with Refractory Central Nervous System Tumors: Experiences of a Clinical Trial Combining Bevacizumab and Temsirolimus
SARINA A. PIHA-PAUL, SANG JOON SHIN, TRIBHAWAN VATS, NANDITA GUHA-THAKURTA, JOANN AARON, MICHAEL RYTTING, EUGENIE KLEINERMAN and RAZELLE KURZROCK

Anticancer Research April 2014, 34 (4) 1939-1945;
You have access
An Early-stage, Non-hypervascular HCC Successfully Treated by Superselective, Bland Transarterial Embolization Using 40-μm Microspheres
TOSHIHIRO TANAKA, SHINSAKU MAEDA, HIDEYUKI NISHIOFUKU, TETSUYA MASADA, TAKESHI SATO, HIROSHI ANAI, HIROSHI SAKAGUCHI and KIMIHIKO KICHIKAWA

Anticancer Research April 2014, 34 (4) 1947-1951;
You have access
Bevacizumab Improves Splenomegaly and Decreases Production of Hyaluronic Acid After L-OHP Based Chemotherapy
YUSUKE ARAKAWA, MITSUO SHIMADA, TOHRU UTSUNOMIYA, SATORU IMURA, YUJI MORINE, TETSUYA IKEMOTO, JUN HANAOKA, MAMI KANAMOTO, SHUICHI IWAHASHI, YU SAITO, SHINICHIRO YAMADA, MICHIHITO ASANOMA, CHIE TAKASU and YOSHIMI BANDO

Anticancer Research April 2014, 34 (4) 1953-1958;
You have access
Full-dose Cisplatin and Oral Vinorelbine Concomitant with Radiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: A Multi-center Phase II Study
ÓSCAR JUAN, ALFREDO SÁNCHEZ-HERNÁNDEZ, SERGIO VÁZQUEZ, JOAQUÍN CASAL, JOSÉ LUIS FIRVIDA, FRANCISCO APARISI, JOSÉ MUÑOZ, JOSÉ GARCÍA-SÁNCHEZ, REGINA GIRONÉS, MARTÍN LÁZARO and VICENTE GINER

Anticancer Research April 2014, 34 (4) 1959-1966;
You have access
Multicenter Phase II Study of Second-line Cetuximab plus Folinic Acid/5-Fluorouracil/Irinotecan (FOLFIRI) in KRAS Wild-type Metastatic Colorectal Cancer: The FLIER Study
SHIGEYOSHI IWAMOTO, SHOICHI HAZAMA, TAKESHI KATO, YASUHIRO MIYAKE, MUTSUMI FUKUNAGA, CHU MATSUDA, HIROYUKI BANDO, JUNICHI SAKAMOTO, KOJI OBA and HIDEYUKI MISHIMA

Anticancer Research April 2014, 34 (4) 1967-1973;
You have access
Phase II Study of Erlotinib for Acquired Resistance to Gefitinib in Patients with Advanced Non-small Cell Lung Cancer
ATSUSHI HORIIKE, NOBUYUKI YAMAMOTO, HISASHI TANAKA, NORIKO YANAGITANI, KEITA KUDO, FUMIYOSHI OHYANAGI, AKIRA ONO, TATEAKI NAITO, HARUYASU MURAKAMI, TAKESHI HORAI and MAKOTO NISHIO

Anticancer Research April 2014, 34 (4) 1975-1981;
You have access
Oncological Outcomes of Hormonal Therapy with a Gonadotropin-releasing Hormone Agonist Combined with a Steroidal or Non-Steroidal Antiandrogen in Patients with Prostate Cancer
TSUKASA IGAWA, TOSHIFUMI TSURUSAKI, KOICHIRO NOMATA, MIKIO HAYASHI, MASATAKA FURUKAWA and HIDEKI SAKAI

Anticancer Research April 2014, 34 (4) 1983-1988;
You have access
Multimodal Approach for Cervical Esophageal Carcinoma: Role of Neoadjuvant Chemotherapy
GEN SUZUKI, HIDEYA YAMAZAKI, ETSUYO OGO, TOSHI ABE, HIDEHIRO ETO, KOICHIRO MURAKI, CHIKAYUKI HATTORI, HIROHITO UMENO, TADASHI NAKASHIMA, TOSHIAKI TANAKA, SATOAKI NAKAMURA and KEN YOSHIDA

Anticancer Research April 2014, 34 (4) 1989-1992;
You have access
Evaluation of Radioprotective Effect of Pilocarpine Ingestion on Salivary Glands
MARCELE JARDIM PIMENTEL, MÁRIO MÁRCIO VASCONCELOS BATISTA FILHO, MARIÂNGELA ARAÚJO, DALIANA QUEIROGA GOMES and LINO JOÃO DA COSTA

Anticancer Research April 2014, 34 (4) 1993-1999;
You have access
Effect of Co-administration of Ketoconazole, a Strong CYP3A Inhibitor, on the Pharmacokinetics, Safety and Tolerability of Navitoclax, a First-in-class Oral Bcl-2 Family Inhibitor, in Cancer Patients
AHMED HAMED SALEM, JIANNING YANG, ALISON GRAHAM, AMITA PATNAIK, KYLE HOLEN, RAJENDRA PRADHAN and HAO XIONG

Anticancer Research April 2014, 34 (4) 2001-2006;
You have access
Impact of Combination Chemotherapy with Itraconazole on Survival for Patients with Recurrent or Persistent Ovarian Clear Cell Carcinoma
HIROSHI TSUBAMOTO, TAKASHI SONODA, MASAAKI YAMASAKI and KAYO INOUE

Anticancer Research April 2014, 34 (4) 2007-2014;
You have access
Comparison of Common Terminology Criteria for Adverse Events v3.0 and Radiation Therapy Oncology Group Toxicity Score System After High-dose-rate Interstitial Brachytherapy as Monotherapy for Prostate Cancer
KEN YOSHIDA, HIDEYA YAMAZAKI, SATOAKI NAKAMARA, KOJI MASUI, TADAYUKI KOTSUMA, HIRONORI AKIYAMA, EIICHI TANAKA and YASUO YOSHIOKA

Anticancer Research April 2014, 34 (4) 2015-2018;
You have access
The Role of Prophylactic Hyperthermic Intraperitoneal Chemotherapy in the Management of Serosal Involved Gastric Cancer
EDOARDO SALADINO, FRANCESCO FLERES, CARMELO MAZZEO, VINCENZO PRUITI, MICHELA SCOLLICA, MAURIZIO ROSSITTO, EUGENIO CUCINOTTA and ANTONIO MACRÌ

Anticancer Research April 2014, 34 (4) 2019-2022;
You have access
A Pilot Study of Cisplatin and Etoposide With and Without Radiotherapy for Advanced Malignant Thymoma
AKIHIRO TAMIYA, AKIHIDE MATSUMURA, TAISUKE TSUJI, MASAHIRO MORIMOTO, KAZUHIRO ASAMI, KYOICHI OKISHIO, SHIGEKI SHIMIZU, HYUNG-EUN YOON, SHINJI ATAGI, MASANORI AKIRA, MASANORI KITAICHI and TOMOYA KAWAGUCHI

Anticancer Research April 2014, 34 (4) 2023-2027;
You have access
Phase I Study of Combination Therapy with Irinotecan, Leucovorin, and Bolus and Continuous-infusion 5-Fluorouracil (FOLFIRI) for Advanced Colorectal Cancer in Japanese Patients
YUSUKE SASAKI, TETSUYA HAMAGUCHI, TATSUHIRO ARAI, AYUMU GOTO, TAKASHI URA, KEI MURO, YASUHIDE YAMADA, KUNIAKI SHIRAO and YASUHIRO SHIMADA

Anticancer Research April 2014, 34 (4) 2029-2034;
You have access
Analysis of Adverse Events of Bevacizumab-containing Systemic Chemotherapy for Metastatic Colorectal Cancer in Japan
TAICHI ISOBE, KEITA UCHINO, CHINATSU MAKIYAMA, HIROSHI ARIYAMA, SHUJI ARITA, SHINGO TAMURA, MASATO KOMODA, HITOSHI KUSABA, TSUYOSHI SHIRAKAWA, TAITO ESAKI, KENJI MITSUGI, SHIGEO TAKAISHI, KOICHI AKASHI and EISHI BABA

Anticancer Research April 2014, 34 (4) 2035-2040;
You have access
ABSTRACTS OF THE FIFTH INTERNATIONAL SYMPOSIUM ON VITAMIN D ANALOGS IN CANCER PREVENTION AND THERAPY
Anticancer Research April 2014, 34 (4) 2041-2059;

Main menu

User menu

Search

Table of Contents

Special Issue on New Anticancer Agents

Reviews

Experimental Studies

Clinical Studies

In this issue

Jump to